Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Government Printing Office, 2013.
Subjects:	Drug approval > United States. Generic drugs > Government policy > United States. Biologicals > Government policy > United States. Drug accessibility > United States. Fees, Administrative > United States. United States. > Food and Drug Administration > Rules and practice.
Online Access:	https://purl.fdlp.gov/GPO/gpo39088 http://purl.fdlp.gov/GPO/gpo39088

Description
Item Description:	Title from title screen (viewed on Aug. 14, 2013). Paper version available for sale by the Superintendent of Documents, U.S. Government Printing Office. "Serial no. 112-114."
Physical Description:	1 online resource (iv, 194 pages) : illustrations
Bibliography:	Includes bibliographical references.